|
| 38030749 | Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. | Br J Cancer | 2024 |
| 38030749 | Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. | Br J Cancer | 2024 |
| 36571512 | The risks of cancer in older women with BRCA pathogenic variants: How far have we come? | Cancer | 2023 |
| 36839209 | An Assessment of Serum Selenium Concentration in Women with Ovarian Cancer. | Nutrients | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 36571512 | The risks of cancer in older women with BRCA pathogenic variants: How far have we come? | Cancer | 2023 |
| 37312208 | Genetic testing for hereditary breast cancer in Poland: 1998-2022. | Hered Cancer Clin Pract | 2023 |
| 37299574 | Serum Essential Elements and Survival after Cancer Diagnosis. | Nutrients | 2023 |
| 37510234 | The <i>APOBEC3B</i> c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population. | Genes (Basel) | 2023 |
| 36977412 | Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank. | Am J Hum Genet | 2023 |
| 37510234 | The <i>APOBEC3B</i> c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population. | Genes (Basel) | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37312208 | Genetic testing for hereditary breast cancer in Poland: 1998-2022. | Hered Cancer Clin Pract | 2023 |
| 36977412 | Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank. | Am J Hum Genet | 2023 |
| 37299574 | Serum Essential Elements and Survival after Cancer Diagnosis. | Nutrients | 2023 |
| 36839209 | An Assessment of Serum Selenium Concentration in Women with Ovarian Cancer. | Nutrients | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 35702492 | Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors. | Breast Care (Basel) | 2022 |
| 35442721 | Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2. | JCO Precis Oncol | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 35382848 | Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland. | Hered Cancer Clin Pract | 2022 |
| 36210504 | Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. | J Natl Cancer Inst | 2022 |
| 35477169 | Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35063280 | Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. | Gynecol Oncol | 2022 |
| 35314380 | Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review. | Eur J Med Genet | 2022 |
| 35313928 | Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor. | Hered Cancer Clin Pract | 2022 |
| 35267933 | An Assessment of Serum Selenium Concentration in Women with Endometrial Cancer. | Nutrients | 2022 |
| 35205705 | Risk of Second Primary Thyroid Cancer in Women with Breast Cancer. | Cancers (Basel) | 2022 |
| 35205233 | An Assessment of <i>GPX1</i> (rs1050450), <i>DIO2</i> (rs225014) and <i>SEPP1</i> (rs7579) Gene Polymorphisms in Women with Endometrial Cancer. | Genes (Basel) | 2022 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 35477169 | Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35442721 | Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2. | JCO Precis Oncol | 2022 |
| 35382848 | Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland. | Hered Cancer Clin Pract | 2022 |
| 35702492 | Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors. | Breast Care (Basel) | 2022 |
| 36210504 | Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. | J Natl Cancer Inst | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 35314380 | Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review. | Eur J Med Genet | 2022 |
| 35313928 | Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor. | Hered Cancer Clin Pract | 2022 |
| 35063280 | Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. | Gynecol Oncol | 2022 |
| 35205705 | Risk of Second Primary Thyroid Cancer in Women with Breast Cancer. | Cancers (Basel) | 2022 |
| 35205233 | An Assessment of <i>GPX1</i> (rs1050450), <i>DIO2</i> (rs225014) and <i>SEPP1</i> (rs7579) Gene Polymorphisms in Women with Endometrial Cancer. | Genes (Basel) | 2022 |
| 35267933 | An Assessment of Serum Selenium Concentration in Women with Endometrial Cancer. | Nutrients | 2022 |
| 32546565 | Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer. | J Med Genet | 2021 |
| 33809461 | Serum Selenium Level Predicts 10-Year Survival after Breast Cancer. | Nutrients | 2021 |
| 34283078 | Blood Arsenic Levels as a Marker of Breast Cancer Risk among <i>BRCA1</i> Carriers. | Cancers (Basel) | 2021 |
| 33478551 | BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update. | Hered Cancer Clin Pract | 2021 |
| 33670479 | Recurrent Mutations in <i>BRCA1</i>, <i>BRCA2</i>, <i>RAD51C</i>, <i>PALB2</i> and <i>CHEK2</i> in Polish Patients with Ovarian Cancer. | Cancers (Basel) | 2021 |
| 32546565 | Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer. | J Med Genet | 2021 |